jeudi 10 décembre 2015

Onco Actu du 10 décembre 2015


1. Biologie

Cancer Treatments May Need To Be Tailored To Each Tumor [NPR]

3.1 Tabac

Tobacco firms challenge plain packaging rules [BBC News]

4. Dépistage, diagnostic et pronostic

Imaging test detects aggressive and treatment-resistant cancers [The Institute of Cancer Research]

5. Traitements

Blocking body’s first immune response could reduce cancer spread [Cancer Research UK]

Turning Red Blood Cells into Versatile Drug Carriers [MIT Technology Review]

5.12 Immunothérapies

Pioneering cancer treatment engineers immune systems to fight disease [The Guardian]

5.2.1 Pharma - Partenariats

Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers [Pfizer]

5.2.3 Pharma - économie

Erytech raises €25M to broaden cancer pipeline ahead of possible Nasdaq IPO [FierceBiotech]

Medigene jumps 33% as cancer vax shows promise in hard-to-treat patients [FierceBiotech]

Cellectis suffers worst day in two years after Pfizer event disappoints investors [FierceBiotech]

New Genmab Darzalex drug results seen increase sales [Reuters]

5.3 Traitements - FDA, EMA,...

"EMA ready to address challenges ahead" [EMA]

Smarter regulation can help cut drug prices, says EU agency head [Reuters]

5.4 Traitements - Economie

We can't ignore a young woman’s plea for a rare cancer drug [The Guardian]

5.7.1 SABCS-communiqués

Multiple Scientific Presentations at the San Antonio Breast Cancer Symposium Highlight the Clinical Utility of the Myriad myRisk(TM) Hereditary Cancer Gene Panel Test [Myriad]

Halozyme Therapeutics and Eisai to present data evaluating the antitumor effects of PEGPH20 in combination with eribulin mesylate in preclinical breast cancer models [Halozyme Therapeutics]

Abstracts at San Antonio Breast Cancer Symposium Highlight ABRAXANE® as a Potential Backbone Therapy in Neoadjuvant and Triple-Negative-Breast Cancer [Celgene]

5.7.2 SABCS-divers

Study links body fat, weight loss, and chromosome length in breast cancer patients [YaleNews]

Older Breast Cancer Patients Defy Survival Models [Duke Medicine]

5.7.3 SABCS-AACR

Pathologic Complete Response to Presurgery Chemotherapy Improves Survival for Patients With Triple-negative Breast Cancer [AACR]

Women With Luminal A Subtype of Breast Cancer Did Not Benefit From Adjuvant Chemotherapy [AACR]

Denosumab Improves Disease-free Survival for Postmenopausal Patients With HR-positive Breast Cancer [AACR]

Capecitabine Improved Outcomes for Breast Cancer Patients With Residual Disease After Presurgery Chemotherapy [AACR]

5.8 ASH

Venetoclax Is A Powerful New Kind of Cancer Drug Effective In Chronic Lymphocytic Leukemia [Forbes]

6. Lutte contre les cancers

Keeping A Cool Head On Cold Cap news [Dr. Len's Blog]

6.6 Publications

The Magic of Peer Review [In the Pipeline]

Cancer researcher contributed "false data" to 11 studies [Retraction Watch]

6.8 Communication

Will Stahl-Timmins: Almost impossible cancer spaghetti [BMJ Blogs]

Is it ok for journalists to attend Bayer-funded training on new cancer treatments? [HealthNewsReview]